We are live on
!
Find out more
PP
Paloma Partners Portfolio holdings
AUM
$510M
1-Year Est. Return
286.05%
This Fund
S&P 500
This Quarter
Est. Return
+3.59%
1 Year Est. Return
+286.05%
3 Year Est. Return
+321.92%
5 Year Est. Return
+284.54%
10 Year Est. Return
+855.7%
AUM
$10.2B
AUM Growth
+$2.21B
(+28%)
Cap. Flow
+$1.91B
Cap. Flow
% of AUM
18.7%
Top 10 Holdings %
Top 10 Hldgs %
42.15%
Holding
2,326
New
523
Increased
761
Reduced
552
Closed
381
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Biogen
BIIB
|
+$88.6M |
| 2 |
Invesco QQQ Trust
QQQ
|
+$55.2M |
| 3 |
Amazon
AMZN
|
+$50.7M |
| 4 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$50.4M |
| 5 |
Apple
AAPL
|
+$27.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
KLA
KLAC
|
+$30.4M |
| 2 |
Wells Fargo
WFC
|
+$18.1M |
| 3 |
State Street SPDR S&P Oil & Gas Exploration & Production ETF
XOP
|
+$13.9M |
| 4 |
STJ
St Jude Medical
STJ
|
+$13.5M |
| 5 |
LNKD
LinkedIn Corporation
LNKD
|
+$13.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 4.46% |
| 2 | Industrials | 3.74% |
| 3 | Financials | 3.69% |
| 4 | Healthcare | 3.55% |
| 5 | Technology | 3.54% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ADPT
1851
DELISTED
Adeptus Health Inc
ADPT
| $168K | ﹤0.01% |
+22,004
| New | +$405K |
|
1852
Madrigal Pharmaceuticals
MDGL
$12.8B
| $161K | ﹤0.01% |
+10,781
| New | +$173K |
|
1853
TETRA Technologies
TTI
$1.11B
| $161K | ﹤0.01% |
+31,948
| New | +$173K |
|
|
ERF
1854
DELISTED
Enerplus Corporation
ERF
| $160K | ﹤0.01% |
16,900
-39,400
| -70% | -$312K |
|
|
ORBC
1855
DELISTED
ORBCOMM, Inc.
ORBC
| $159K | ﹤0.01% |
+19,237
| New | +$169K |
|
1856
Groupon
GRPN
$1.05B
| $154K | ﹤0.01% |
2,310
-5,966
| -72% | -$502K |
|
1857
Hudbay
HBM
$9.76B
| $154K | ﹤0.01% |
+27,000
| New | +$144K |
|
1858
8x8 Inc
EGHT
$262M
| $151K | ﹤0.01% |
+10,546
| New | +$153K |
|
1859
Hecla Mining
HL
$10B
| $151K | ﹤0.01% |
28,948
+16,031
| +124% | +$94K |
|
1860
CALL
United States Oil Fund
USO
$2.1B
| $151K | ﹤0.01% |
+1,613
| New | +$142K |
|
1861
OneSpan
OSPN
$567M
| $150K | ﹤0.01% |
+11,000
| New | +$165K |
|
1862
Telefônica Brasil
VIV
$22.6B
| $150K | ﹤0.01% |
+11,228
| New | +$151K |
|
|
BSMX
1863
DELISTED
Banco Santander México, S, A., Institución de Banca Múltiple, Grupo Financiero Santander México
BSMX
| $150K | ﹤0.01% |
+20,899
| New | +$168K |
|
1864
Compañía de Minas Buenaventura
BVN
$7.93B
| $148K | ﹤0.01% |
13,116
-129
| -1% | -$1.54K |
|
|
CS
1865
DELISTED
Credit Suisse Group
CS
| $147K | ﹤0.01% |
10,300
-3,244
| -24% | -$45.5K |
|
1866
Innoviva
INVA
$1.59B
| $145K | ﹤0.01% |
+13,560
| New | +$142K |
|
1867
Petrobras
PBR
$117B
| $145K | ﹤0.01% |
14,368
-27,866
| -66% | -$298K |
|
1868
B2Gold
BTG
$5.1B
| $143K | ﹤0.01% |
60,540
-1,740,626
| -97% | -$4.32M |
|
1869
MannKind Corp
MNKD
$1.26B
| $143K | ﹤0.01% |
+44,915
| New | +$130K |
|
|
GAU
1870
Galiano Gold
GAU
$475M
| $141K | ﹤0.01% |
+46,000
| New | +$159K |
|
1871
Vipshop
VIPS
$7.06B
| $140K | ﹤0.01% |
+12,681
| New | +$164K |
|
|
AUY
1872
DELISTED
Yamana Gold, Inc.
AUY
| $138K | ﹤0.01% |
48,998
-1,322
| -3% | -$4.32K |
|
|
RSO
1873
DELISTED
Resource Capital Corp.
RSO
| $138K | ﹤0.01% |
+16,564
| New | +$172K |
|
|
SYUT
1874
DELISTED
Synutra International, Inc.
SYUT
| $137K | ﹤0.01% |
+25,599
| New | +$123K |
|
|
IMGN
1875
DELISTED
Immunogen Inc
IMGN
| $135K | ﹤0.01% |
+66,414
| New | +$133K |
|
Similar funds
JF
PWMG
NIEF
HIM
MCA
OA
BWP
MC
Paloma Partners's Q4 2016 Portfolio in Review
As of Q4 2016, Paloma Partners held 2,326 positions worth $10.2B, up 28% from $7.99B the previous quarter. Its ten largest holdings account for 42% of the portfolio.
Paloma Partners deployed $1.91B of net new capital in Q4 2016, opening 523 new positions and adding to 761 existing holdings. Its largest new stake was NXP Semiconductors: 253,000 shares worth $24.8M.
By sector, the portfolio is most concentrated in Consumer Discretionary at 4.5% of assets, up from 3.4% a quarter earlier, followed by Industrials and Financials.
On the sell side, the largest reduction was KLA, an estimated $30.4M trimmed.
- Paloma Partners's largest Q4 2016 buy was NXP Semiconductors: 253,000 shares worth $24.8M.
- Paloma Partners added most to Biogen in Q4 2016, an estimated $88.6M increase.
- Paloma Partners's biggest Q4 2016 reduction was KLA, cutting an estimated $30.4M.
- Paloma Partners fully exited St Jude Medical in Q4 2016, selling an estimated $13.5M.
- Paloma Partners's ten largest holdings make up 42% of its $10.2B portfolio in Q4 2016.
- Paloma Partners opened 523 new positions and closed 381 in Q4 2016.
- Paloma Partners's portfolio value rose 28% quarter-over-quarter to $10.2B.
Based on Paloma Partners's 13F filing for Q4 2016, filed 14 Feb 2017.